Treating an established episode of delirium in palliative care: Expert opinion and review of the current evidence base with recommendations for future development

Journal of Pain and Symptom Management

Volumn 48, Issue 2, 2014, Pages 231-248

  Bush, Shirley H ^a,c   Kanji, Salmaan ^d,e   Pereira, José L ^a,c   Davis, Daniel H J ^f   Currow, David C ^g   Meagher, David J ^h   Rabheru, Kiran ^b,e   Wright, David Kenneth ⁱ   Bruera, Eduardo ^j   Agar, Meera ^g,k,l   Hartwick, Michael ^a,e   Gagnon, Pierre R ^m,n   Gagnon, Bruno ^m,o   Breitbart, William ^p   Regnier, Laura ^b,e   Lawlor, Peter G ^a,b,c,d  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c BRUYÈRE RESEARCH INSTITUTE   (Canada)

^d OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^e UNIVERSITY OF OTTAWA   (Canada)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^g FLINDERS UNIVERSITY   (Australia)

^h UNIVERSITY OF LIMERICK   (Ireland)

ⁱ MCGILL UNIVERSITY   (Canada)

^j UNIVERSITY OF TEXAS   (United States)

^k UNIVERSITY OF NEW SOUTH WALES   (Australia)

^l Braeside Hospital   (Australia)

^m UNIVERSITÉ LAVAL   (Canada)

ⁿ LAVAL UNIVERSITY   (Canada)

^o Université Laval   (Canada)

^p MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

more..

Author keywords

decision making; Delirium; evidence based medicine; hospices; palliative care; therapeutics

Indexed keywords

HALOPERIDOL; NEUROLEPTIC AGENT;

DELIRIUM; HUMAN; PALLIATIVE THERAPY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ANTIPSYCHOTIC AGENTS; DELIRIUM; HALOPERIDOL; HUMANS; PALLIATIVE CARE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84905899499     PISSN: 08853924     EISSN: 18736513     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2013.07.018     Document Type: Article

References (144)

1. A. Hosie, P.M. Davidson, M. Agar, C.R. Sanderson, and J. Phillips Delirium prevalence, incidence, and implications for screening in specialist palliative care inpatient settings: a systematic review Palliat Med 27 2013 486 498
2. M. Agar, and P. Lawlor Delirium in cancer patients: a focus on treatment-induced psychopathology Curr Opin Oncol 20 2008 360 366
3. A. Caraceni, O. Nanni, and M. Maltoni et al. Impact of delirium on the short term prognosis of advanced cancer patients. Italian Multicenter Study Group on Palliative Care Cancer 89 2000 1145 1149
4. N. Siddiqi, A.O. House, and J.D. Holmes Occurrence and outcome of delirium in medical in-patients: a systematic literature review Age Ageing 35 2006 350 364
5. D.J. Meagher Delirium: optimising management BMJ 322 2001 144 149
6. S.K. Inouye Delirium in older persons N Engl J Med 354 2006 1157 1165
7. L. Michaud, C. Bula, and A. Berney et al. Delirium: guidelines for general hospitals J Psychosom Res 62 2007 371 383
8. A.M. MacLullich, and R.J. Hall Who understands delirium? Age Ageing 40 2011 412 414
9. American Psychiatric Association Practice guideline for the treatment of patients with delirium Am J Psychiatry 156 1999 1 20
10. National Institute for Health and Clinical Excellence (NICE). Delirium: Diagnosis, prevention and management, Clinical guidelines, CG103. 2010. Available from http://www.nice.org.uk/cg103. Accessed May 19, 2013.
11. Royal College of Physicians and British Geriatrics Society The prevention, diagnosis and management of delirium in older people: National guidelines 2006 Royal College of Physicians Salisbury, UK
12. Canadian Coalition for Seniors' Mental Health Guideline on the assessment and treatment of delirium in older adults at the end of life. Adapted from the CCSMH national guidelines for seniors' mental health. The assessment and treatment of delirium 2010 CCSMH Toronto
13. G. O'Malley, M. Leonard, D. Meagher, and S.T. O'Keeffe The delirium experience: a review J Psychosom Res 65 2008 223 228
14. J.S. Partridge, F.C. Martin, D. Harari, and J.K. Dhesi The delirium experience: what is the effect on patients, relatives and staff and what can be done to modify this? Int J Geriatr Psychiatry 28 2013 804 812
15. M. Maltoni, E. Scarpi, and M. Rosati et al. Palliative sedation in end-of-life care and survival: a systematic review J Clin Oncol 30 2012 1378 1383
16. J. Napolskikh, D. Selby, and M. Bennett et al. Demographic profile and utilization statistics of a Canadian inpatient palliative care unit within a tertiary care setting Curr Oncol 16 2009 49 54
17. S. Kaasa, K. Torvik, N. Cherny, G. Hanks, and F. de Conno Patient demographics and centre description in European palliative care units Palliat Med 21 2007 15 22
18. D. Hui, I. Glitza, G. Chisholm, S. Yennu, and E. Bruera Attrition rates, reasons, and predictive factors in supportive care and palliative oncology clinical trials Cancer 119 2013 1098 1105
19. K.H. Whittamore, S.E. Goldberg, and J.R. Gladman et al. The diagnosis, prevalence and outcome of delirium in a cohort of older people with mental health problems on general hospital wards Int J Geriatr Psychiatry 29 2014 32 40
20. T.G. Fong, S.R. Tulebaev, and S.K. Inouye Delirium in elderly adults: diagnosis, prevention and treatment Nat Rev Neurol 5 2009 210 220
21. M.D. Buffum, E. Hutt, V.T. Chang, M.H. Craine, and A.L. Snow Cognitive impairment and pain management: review of issues and challenges J Rehabil Res Dev 44 2007 315 330
22. P.G. Lawlor, B. Gagnon, and I.L. Mancini et al. Occurrence causes, and outcome of delirium in patients with advanced cancer: a prospective study Arch Intern Med 160 2000 786 794
23. T. Morita, Y. Tei, J. Tsunoda, S. Inoue, and S. Chihara Underlying pathologies and their associations with clinical features in terminal delirium of cancer patients J Pain Symptom Manage 22 2001 997 1006
24. M. Leonard, B. Raju, and M. Conroy et al. Reversibility of delirium in terminally ill patients and predictors of mortality Palliat Med 22 2008 848 854
25. S.A. Irwin, R.D. Pirrello, J.M. Hirst, G.T. Buckholz, and F.D. Ferris Clarifying delirium management: practical, evidenced-based, expert recommendations for clinical practice J Palliat Med 16 2013 423 435
26. I.J. Higginson, and C.J. Evans What is the evidence that palliative care teams improve outcomes for cancer patients and their families? Cancer J 16 2010 423 435
27. W. Breitbart, C. Gibson, and A. Tremblay The delirium experience: delirium recall and delirium-related distress in hospitalized patients with cancer, their spouses/caregivers, and their nurses Psychosomatics 43 2002 183 194
28. T. Morita, K. Hirai, Y. Sakaguchi, S. Tsuneto, and Y. Shima Family-perceived distress from delirium-related symptoms of terminally ill cancer patients Psychosomatics 45 2004 107 113
29. M.K. Buss, L.C. Vanderwerker, and S.K. Inouye et al. Associations between caregiver-perceived delirium in patients with cancer and generalized anxiety in their caregivers J Palliat Med 10 2007 1083 1092
30. M. Namba, T. Morita, and C. Imura et al. Terminal delirium: families' experience Palliat Med 21 2007 587 594
31. E. Bruera, S.H. Bush, and J. Willey et al. Impact of delirium and recall on the level of distress in patients with advanced cancer and their family caregivers Cancer 115 2009 2004 2012
32. World Health Organization. WHO definition of palliative care. 2013. Available from http://www.who.int/cancer/palliative/definition/en/. Accessed May 19, 2013.
33. P. Gagnon, C. Charbonneau, and P. Allard et al. Delirium in advanced cancer: a psychoeducational intervention for family caregivers J Palliat Care 18 2002 253 261
34. H. Otani, T. Morita, and S. Uno et al. Usefulness of the leaflet-based intervention for family members of terminally ill cancer patients with delirium J Palliat Med 16 2013 419 422
35. T. Morita, T. Akechi, and M. Ikenaga et al. Terminal delirium: recommendations from bereaved families' experiences J Pain Symptom Manage 34 2007 579 589
36. K.L. Lapane, C.M. Hughes, L.A. Daiello, K.A. Cameron, and J. Feinberg Effect of a pharmacist-led multicomponent intervention focusing on the medication monitoring phase to prevent potential adverse drug events in nursing homes J Am Geriatr Soc 59 2011 1238 1245
37. S.H. Bush, and E. Bruera The assessment and management of delirium in cancer patients Oncologist 14 2009 1039 1049
38. N. Jackson, J. Doherty, and S. Coulter Neuropsychiatric complications of commonly used palliative care drugs Postgrad Med J 84 2008 121 126
39. J.D. Gaudreau, P. Gagnon, F. Harel, M.A. Roy, and A. Tremblay Psychoactive medications and risk of delirium in hospitalized cancer patients J Clin Oncol 23 2005 6712 6718
40. M. Agar, D. Currow, and J. Plummer et al. Changes in anticholinergic load from regular prescribed medications in palliative care as death approaches Palliat Med 23 2009 257 265
41. P.J. Daeninck, and E. Bruera Opioid use in cancer pain. Is a more liberal approach enhancing toxicity? Acta Anaesthesiol Scand 43 1999 924 938
42. S. Mercadante, and E. Bruera Opioid switching: a systematic and critical review Cancer Treat Rev 32 2006 304 315
43. N.D. de Stoutz, E. Bruera, and M. Suarez-Almazor Opioid rotation for toxicity reduction in terminal cancer patients J Pain Symptom Manage 10 1995 378 384
44. E. Bruera, J.J. Franco, M. Maltoni, S. Watanabe, and M. Suarez-Almazor Changing pattern of agitated impaired mental status in patients with advanced cancer: association with cognitive monitoring, hydration, and opioid rotation J Pain Symptom Manage 10 1995 287 291
45. R.S. Morrison, J. Magaziner, and M. Gilbert et al. Relationship between pain and opioid analgesics on the development of delirium following hip fracture J Gerontol A Biol Sci Med Sci 58 2003 76 81
46. Y. Kishi, M. Kato, T. Okuyama, and S. Thurber Treatment of delirium with risperidone in cancer patients Psychiatry Clin Neurosci 66 2012 411 417
47. S. Boettger, and W. Breitbart An open trial of aripiprazole for the treatment of delirium in hospitalized cancer patients Palliat Support Care 9 2011 351 357
48. A.W. Oldenbeuving, P.L. de Kort, B.P. Jansen, L.J. Kappelle, and G. Roks A pilot study of rivastigmine in the treatment of delirium after stroke: a safe alternative BMC Neurol 8 2008 34
49. B. Maneeton, N. Maneeton, and M. Srisurapanont An open-label study of quetiapine for delirium J Med Assoc Thai 90 2007 2158 2163
50. T. Takeuchi, K. Furuta, and T. Hirasawa et al. Perospirone in the treatment of patients with delirium Psychiatry Clin Neurosci 61 2007 67 70
51. D.A. Straker, P.A. Shapiro, and P.R. Muskin Aripiprazole in the treatment of delirium Psychosomatics 47 2006 385 391
52. D. Mittal, N.A. Jimerson, and E.P. Neely et al. Risperidone in the treatment of delirium: results from a prospective open-label trial J Clin Psychiatry 65 2004 662 667
53. E. Parellada, I. Baeza, J. de Pablo, and G. Martinez Risperidone in the treatment of patients with delirium J Clin Psychiatry 65 2004 348 353
54. C.U. Pae, S.J. Lee, C.U. Lee, C. Lee, and I.H. Paik A pilot trial of quetiapine for the treatment of patients with delirium Hum Psychopharmacol 19 2004 125 127
55. Y. Sasaki, T. Matsuyama, and S. Inoue et al. A prospective, open-label, flexible-dose study of quetiapine in the treatment of delirium J Clin Psychiatry 64 2003 1316 1321
56. N. Horikawa, T. Yamazaki, and K. Miyamoto et al. Treatment for delirium with risperidone: results of a prospective open trial with 10 patients Gen Hosp Psychiatry 25 2003 289 292
57. K.Y. Kim, G.M. Bader, V. Kotlyar, and D. Gropper Treatment of delirium in older adults with quetiapine J Geriatr Psychiatry Neurol 16 2003 29 31
58. W. Breitbart, A. Tremblay, and C. Gibson An open trial of olanzapine for the treatment of delirium in hospitalized cancer patients Psychosomatics 43 2002 175 182
59. K.S. Kim, C.U. Pae, J.H. Chae, W.M. Bahk, and T. Jun An open pilot trial of olanzapine for delirium in the Korean population Psychiatry Clin Neurosci 55 2001 515 519
60. T. Akechi, Y. Uchitomi, and H. Okamura et al. Usage of haloperidol for delirium in cancer patients Support Care Cancer 4 1996 390 392
61. G.I. Tagarakis, C. Voucharas, and F. Tsolaki et al. Ondasetron versus haloperidol for the treatment of postcardiotomy delirium: a prospective, randomized, double-blinded study J Cardiothorac Surg 7 2012 25
62. S.M. Hakim, A.I. Othman, and D.O. Naoum Early treatment with risperidone for subsyndromal delirium after on-pump cardiac surgery in the elderly: a randomized trial Anesthesiology 116 2012 987 997
63. J.W. Devlin, Y. Skrobik, and R.R. Riker et al. Impact of quetiapine on resolution of individual delirium symptoms in critically ill patients with delirium: a post-hoc analysis of a double-blind, randomized, placebo-controlled study Crit Care 15 2011 R215
64. S. Grover, V. Kumar, and S. Chakrabarti Comparative efficacy study of haloperidol, olanzapine and risperidone in delirium J Psychosom Res 71 2011 277 281
65. M.M. van Eijk, K.C. Roes, and M.L. Honing et al. Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial Lancet 376 2010 1829 1837
66. T.A. Tahir, E. Eeles, and V. Karapareddy et al. A randomized controlled trial of quetiapine versus placebo in the treatment of delirium J Psychosom Res 69 2010 485 490
67. R. Overshott, M. Vernon, J. Morris, and A. Burns Rivastigmine in the treatment of delirium in older people: a pilot study Int Psychogeriatr 22 2010 812 818
68. S.W. Kim, J.A. Yoo, and S.Y. Lee et al. Risperidone versus olanzapine for the treatment of delirium Hum Psychopharmacol 25 2010 298 302
69. T.D. Girard, P.P. Pandharipande, and S.S. Carson et al. Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: the MIND randomized, placebo-controlled trial Crit Care Med 38 2010 428 437
70. J.W. Devlin, R.J. Roberts, and J.J. Fong et al. Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind, placebo-controlled pilot study Crit Care Med 38 2010 419 427
71. M.C. Reade, K. O'Sullivan, and S. Bates et al. Dexmedetomidine vs. haloperidol in delirious, agitated, intubated patients: a randomised open-label trial Crit Care 13 2009 R75
72. K.U. Lee, W.Y. Won, and H.K. Lee et al. Amisulpride versus quetiapine for the treatment of delirium: a randomized, open prospective study Int Clin Psychopharmacol 20 2005 311 314
73. C.S. Han, and Y.K. Kim A double-blind trial of risperidone and haloperidol for the treatment of delirium Psychosomatics 45 2004 297 301
74. Y.K. Skrobik, N. Bergeron, M. Dumont, and S.B. Gottfried Olanzapine vs. haloperidol: treating delirium in a critical care setting Intensive Care Med 30 2004 444 449
75. J.Y. Kim, I.K. Jung, and C. Han et al. Antipsychotics and dopamine transporter gene polymorphisms in delirium patients Psychiatry Clin Neurosci 59 2005 183 188
76. W. Breitbart, R. Marotta, and M.M. Platt et al. A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients Am J Psychiatry 153 1996 231 237
77. Agar M. Oral risperidone, oral haloperidol, and oral placebo in the management of delirium in palliative care. 2013. Available from http://apps.who.int/trialsearch/Trial.aspx?TrialID=ACTRN12607000562471. Accessed May 1, 2013.
78. D.C. Currow, M. Agar, J. Tieman, and A.P. Abernethy Multi-site research allows adequately powered palliative care trials; web-based data management makes it achievable today Palliat Med 22 2008 91 92
79. T.M. Shelby-James, J. Hardy, and M. Agar et al. Designing and conducting randomized controlled trials in palliative care: a summary of discussions from the 2010 clinical research forum of the Australian Palliative Care Clinical Studies Collaborative Palliat Med 26 2012 1042 1047
80. H. Shinno, T. Matsuoka, and O. Yamamoto et al. Successful treatment with quetiapine for delirium in terminally ill cancer patients Psychogeriatrics 7 2007 64 68
81. D.J. Meagher, L. McLoughlin, and M. Leonard et al. What do we really know about the treatment of delirium with antipsychotics? Ten key issues for delirium pharmacotherapy Am J Geriatr Psychiatry 21 2013 1223 1238
82. A.F. Leentjens, J. Rundell, and T. Rummans et al. Delirium: an evidence-based medicine (EBM) monograph for psychosomatic medicine practice, commissioned by the Academy of Psychosomatic Medicine (APM) and the European Association of Consultation Liaison Psychiatry and Psychosomatics (EACLPP) J Psychosom Res 73 2012 149 152
83. E. Lonergan, A.M. Britton, J. Luxenberg, and T. Wyller Antipsychotics for delirium Cochrane Database Syst Rev 2007 CD005594
84. J.H. Flaherty, J.P. Gonzales, and B. Dong Antipsychotics in the treatment of delirium in older hospitalized adults: a systematic review J Am Geriatr Soc 59 Suppl 2 2011 S269 S276
85. B. Candy, K.C. Jackson, and L. Jones et al. Drug therapy for delirium in terminally ill adult patients Cochrane Database Syst Rev 2012 CD004770
86. P. Gagnon Treatment of delirium in supportive and palliative care Curr Opin Support Palliat Care 2 2007 60 66
87. A. Caraceni, and F. Simonetti Palliating delirium in patients with cancer Lancet Oncol 10 2009 164 172
88. J. Vella-Brincat, and A.D. Macleod Haloperidol in palliative care Palliat Med 18 2004 195 201
89. R. Twycross, A. Wilcock, M. Dean, and B. Kennedy PCF: Palliative care formulary, Canadian edition 2010 Palliativedrugs.com Ltd. Nottingham, UK
90. D. Hui, S.H. Bush, and L.E. Gallo et al. Neuroleptic dose in the management of delirium in patients with advanced cancer J Pain Symptom Manage 39 2010 186 196
91. F. Adams, F. Fernandez, and B.S. Andersson Emergency pharmacotherapy of delirium in the critically ill cancer patient Psychosomatics 27 1986 33 38
92. R.R. Riker, G.L. Fraser, and P.M. Cox Continuous infusion of haloperidol controls agitation in critically ill patients Crit Care Med 22 1994 433 440
93. D.M. Hipp, and E.W. Ely Pharmacological and nonpharmacological management of delirium in critically ill patients Neurotherapeutics 9 2012 158 175
94. J. Barr, G.L. Fraser, and K. Puntillo et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit Crit Care Med 41 2013 263 306
95. J.A. Spiller, and J.C. Keen Hypoactive delirium: assessing the extent of the problem for inpatient specialist palliative care Palliat Med 20 2006 17 23
96. D. Meagher Motor subtypes of delirium: past, present and future Int Rev Psychiatry 21 2009 59 73
97. D.J. Meagher, M. Leonard, and S. Donnelly et al. A longitudinal study of motor subtypes in delirium: relationship with other phenomenology, etiology, medication exposure and prognosis J Psychosom Res 71 2011 395 403
98. M. Leonard, S. Donnelly, M. Conroy, P. Trzepacz, and D.J. Meagher Phenomenological and neuropsychological profile across motor variants of delirium in a palliative-care unit J Neuropsychiatry Clin Neurosci 23 2011 180 188
99. S. Boettger, and W. Breitbart Phenomenology of the subtypes of delirium: phenomenological differences between hyperactive and hypoactive delirium Palliat Support Care 9 2011 129 135
100. M.M. Platt, W. Breitbart, and M. Smith et al. Efficacy of neuroleptics for hypoactive delirium J Neuropsychiatry Clin Neurosci 6 1994 66 67
101. D. Meagher, and M. Leonard The active management of delirium: improving detection and treatment Adv Psychiatr Treat 14 2008 292 301
102. W. Breitbart, and Y. Alici Evidence-based treatment of delirium in patients with cancer J Clin Oncol 30 2012 1206 1214
103. S. Boettger, and W. Breitbart Atypical antipsychotics in the management of delirium: a review of the empirical literature Palliat Support Care 3 2005 227 237
104. P.J. Weiden, J.J. Mann, G. Haas, M. Mattson, and A. Frances Clinical nonrecognition of neuroleptic-induced movement disorders: a cautionary study Am J Psychiatry 144 1987 1148 1153
105. M.A. Menza, G.B. Murray, V.F. Holmes, and W.A. Rafuls Decreased extrapyramidal symptoms with intravenous haloperidol J Clin Psychiatry 48 1987 278 280
106. G. Walker, A. Wilcock, and A.M. Carey et al. Prolongation of the QT interval in palliative care patients J Pain Symptom Manage 26 2003 855 859
107. W.A. Ray, C.P. Chung, K.T. Murray, K. Hall, and C.M. Stein Atypical antipsychotic drugs and the risk of sudden cardiac death N Engl J Med 360 2009 225 235
108. D.M. Roden Drug-induced prolongation of the QT interval N Engl J Med 350 2004 1013 1022
109. D. Pickham, E. Helfenbein, and J.A. Shinn et al. High prevalence of corrected QT interval prolongation in acutely ill patients is associated with mortality: results of the QT in Practice (QTIP) Study Crit Care Med 40 2012 394 399
110. U.S.Food and Drug Administration. TdP - low risk drugs (<0.1%). 2013. Available from http://www.fda.gov/ohrms/dockets/ac/01/slides/3746s-01-Ruskin/ sld027.htm. Accessed March 26, 2013.
111. U.S.Food and Drug Administration. Information for healthcare professionals: Haloperidol (marketed as Haldo, Haldol Decanoate and Haldol Lactate) Available from http://www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformationforPatientsandProviders/ DrugSafetyInformationforHeathcareProfessionals/ucm085203.htm Accessed March 26, 2013.
112. M.T. Blom, A. Bardai, and B.C. van Munster et al. Differential changes in QTc duration during in-hospital haloperidol use PLoS One 6 2011 e23728
113. L.S. Schneider, K. Dagerman, and P.S. Insel Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials Am J Geriatr Psychiatry 14 2006 191 210
114. H.C. Kales, H.M. Kim, and K. Zivin et al. Risk of mortality among individual antipsychotics in patients with dementia Am J Psychiatry 169 2012 71 79
115. M. Elie, K. Boss, and M.G. Cole et al. A retrospective, exploratory, secondary analysis of the association between antipsychotic use and mortality in elderly patients with delirium Int Psychogeriatr 21 2009 588 592
116. B. Gagnon, G. Low, and G. Schreier Methylphenidate hydrochloride improves cognitive function in patients with advanced cancer and hypoactive delirium: a prospective clinical study Rev Psychiatr Neurosci 30 2005 100 107
117. M. Hanania, and E. Kitain Melatonin for treatment and prevention of postoperative delirium Anesth Analg 94 2002 338 339
118. J.A. Bourgeois, A.K. Koike, J.E. Simmons, S. Telles, and C. Eggleston Adjunctive valproic acid for delirium and/or agitation on a consultation-liaison service: a report of six cases J Neuropsychiatry Clin Neurosci 17 2005 232 238
119. O. Bayindir, M. Guden, B. Akpinar, I. Sanisoglu, and E. Sagbas Ondansetron hydrochloride for the treatment of delirium after coronary artery surgery J Thorac Cardiovasc Surg 121 2001 176 177
120. J.M. Leung, L.P. Sands, and M. Rico et al. Pilot clinical trial of gabapentin to decrease postoperative delirium in older patients Neurology 67 2006 1251 1253
121. N. Slatkin, and M. Rhiner Treatment of opioid-induced delirium with acetylcholinesterase inhibitors: a case report J Pain Symptom Manage 27 2004 268 273
122. B. Liptzin, A. Laki, J.L. Garb, R. Fingeroth, and R. Krushell Donepezil in the prevention and treatment of post-surgical delirium Am J Geriatr Psychiatry 13 2005 1100 1106
123. E.L. Sampson, P.R. Raven, and P.N. Ndhlovu et al. A randomized, double-blind, placebo-controlled trial of donepezil hydrochloride (Aricept) for reducing the incidence of postoperative delirium after elective total hip replacement Int J Geriatr Psychiatry 22 2007 343 349
124. E.R. Marcantonio, K. Palihnich, P. Appleton, and R.B. Davis Pilot randomized trial of donepezil hydrochloride for delirium after hip fracture J Am Geriatr Soc 59 Suppl 2 2011 S282 S288
125. A. Morandi, C.G. Hughes, and T.D. Girard et al. Statins and brain dysfunction: a hypothesis to reduce the burden of cognitive impairment in patients who are critically ill Chest 140 2011 580 585
126. R. Katznelson, G.N. Djaiani, and M.A. Borger et al. Preoperative use of statins is associated with reduced early delirium rates after cardiac surgery Anesthesiology 110 2009 67 73
127. N.I. Cherny, and L. Radbruch European Association for Palliative Care (EAPC) recommended framework for the use of sedation in palliative care Palliat Med 23 2009 581 593
128. M.M. Dean, V. Cellarius, and B. Henry et al. Framework for continuous palliative sedation therapy in Canada J Palliat Med 15 2012 870 879
129. A. de Graeff, and M. Dean Palliative sedation therapy in the last weeks of life: a literature review and recommendations for standards J Palliat Med 10 2007 67 85
130. E. Prommer The use of levomepromazine in palliative care Eur J Palliat Care 12 2005 8 10
131. I. Dietz, A. Schmitz, I. Lampey, and C. Schulz Evidence for the use of levomepromazine for symptom control in the palliative care setting: a systematic review BMC Palliat Care 12 2013 2
132. M.G. Cole, J. McCusker, and F. Bellavance et al. Systematic detection and multidisciplinary care of delirium in older medical inpatients: a randomized trial CMAJ 167 2002 753 759
133. A.M. Mudge, C. Maussen, J. Duncan, and C.P. Denaro Improving quality of delirium care in a general medical service with established interdisciplinary care: a controlled trial Intern Med J 43 2013 270 277
134. D.J. Meagher, D. O'Hanlon, E. O'Mahony, and P.R. Casey The use of environmental strategies and psychotropic medication in the management of delirium Br J Psychiatry 168 1996 512 515
135. M. Zimberg, and S. Berenson Delirium in patients with cancer: nursing assessment and intervention Oncol Nurs Forum 17 1990 529 538
136. J. McCusker, M. Cole, and M. Abrahamowicz et al. Environmental risk factors for delirium in hospitalized older people J Am Geriatr Soc 49 2001 1327 1334
137. J.H. Flaherty, and M.O. Little Matching the environment to patients with delirium: lessons learned from the delirium room, a restraint-free environment for older hospitalized adults with delirium J Am Geriatr Soc 59 Suppl 2 2011 S295 S300
138. D.P. Seitz, S.S. Gill, and L.T. van Zyl Antipsychotics in the treatment of delirium: a systematic review J Clin Psychiatry 68 2007 11 21
139. H. Lacasse, M.M. Perreault, and D.R. Williamson Systematic review of antipsychotics for the treatment of hospital-associated delirium in medically or surgically ill patients Ann Pharmacother 40 2006 1966 1973
140. R.S. Bourne, T.A. Tahir, M. Borthwick, and E.L. Sampson Drug treatment of delirium: past, present and future J Psychosom Res 65 2008 273 282
141. C.G. Hughes, N.E. Brummel, E.E. Vasilevskis, T.D. Girard, and P.P. Pandharipande Future directions of delirium research and management Best Pract Res Clin Anaesthesiol 26 2012 395 405
142. P.T. Trzepacz, R. Bourne, and S. Zhang Designing clinical trials for the treatment of delirium J Psychosom Res 65 2008 299 307
143. D.C. Currow, J.L. Plummer, J.S. Kutner, G.P. Samsa, and A.P. Abernethy Analyzing phase III studies in hospice/palliative care. A solution that sits between intention-to-treat and per protocol analyses: the palliative-modified ITT analysis J Pain Symptom Manage 44 2012 595 603
144. S. O'Hanlon, N. O'Regan, and A.M. Maclullich et al. Improving delirium care through early intervention: from bench to bedside to boardroom J Neurol Neurosurg Psychiatry 2013 Jan 25 [Epub ahead of print]